GILD+26.01%20.0%
MRNA+615.58%20.0%
NVAX+28.17%20.0%
PCVX+54.83%20.0%
PFE+10.22%20.0%
As of Oct 9, 2026, 4:27 AM ET
MedTech Short '25: Vaccine Makers Constituents
Gilead Sciences, Inc.GILD | 20.0% | 0.17% | -3.36% | 1.00% | -0.27% | 19.85% | -1.24% | 31.47% | 26.01% | 75.31% | 148.57% | $182.40B |
Moderna, Inc.MRNA | 20.0% | 0.26% | -0.14% | 45.27% | 4.27% | 568.02% | 267.74% | 610.68% | 615.58% | 237.39% | -35.39% | $78.17B |
Novavax, Inc.NVAX | 20.0% | -1.87% | 1.94% | 11.78% | 3.87% | 63.84% | 8.58% | 84.11% | 28.17% | -15.57% | -93.29% | $1.81B |
Pfizer Inc.PFE | 20.0% | -0.64% | -3.13% | 0.14% | -1.07% | 11.73% | 0.61% | 12.63% | 10.22% | -1.58% | -23.03% | $158.56B |
Vaxcyte, Inc.PCVX | 20.0% | -2.90% | 11.58% | 9.25% | 15.99% | 40.91% | 5.30% | 92.98% | 54.83% | -41.82% | 169.21% | $9.39B |
| Theme return | — | 1.00% | -1.38% | -11.22% | -4.78% | -74.88% | -24.57% | -107.56% | -73.66% | -32.38% | -10.75% | — |
| Average | 20.0% | -1.00% | 1.38% | 13.49% | 4.56% | 140.87% | 56.20% | 166.37% | 146.96% | 50.74% | 33.21% | $86.06B |
| Median | 20.0% | -0.64% | -0.14% | 9.25% | 3.87% | 40.91% | 5.30% | 84.11% | 28.17% | -1.58% | -23.03% | $78.17B |
| Std Dev | 0.0% | 1.22% | 5.47% | 16.52% | 6.10% | 214.34% | 105.83% | 224.23% | 234.75% | 101.14% | 105.52% | $74.26B |
| Min | 20.0% | -2.90% | -3.36% | 0.14% | -1.07% | 11.73% | -1.24% | 12.63% | 10.22% | -41.82% | -93.29% | $1.81B |
| Max | 20.0% | 0.26% | 11.58% | 45.27% | 15.99% | 568.02% | 267.74% | 610.68% | 615.58% | 237.39% | 169.21% | $182.40B |
| % Positive Tickers | 40.00% | 40.00% | 100.00% | 60.00% | 100.00% | 80.00% | 100.00% | 100.00% | 40.00% | 40.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort